Implementing a Pharmacogenomics Program
The future of precision medicine depends on IT-enabled pharmacogenomic testing.
Read MorePosted by Elaine Sanchez Wilson | May 22, 2017 | Molecular Diagnostics |
The future of precision medicine depends on IT-enabled pharmacogenomic testing.
Read MorePosted by Steve Halasey | May 15, 2017 | Uncategorized |
CLP recently spoke with Eric B. Compton, MBA, chief operating officer at Hologic, Inc, to find out more about current and future policy initiatives that AdvaMedDx expects to advance.
Read MorePosted by Elaine Sanchez Wilson | May 9, 2017 | Molecular Diagnostics |
Under the terms of the agreement, SpeeDx will submit its ResistancePlus MG test to FDA upon successful validation of its use on the Applied Biosystems 7500 Fast Dx real-time polymerase chain reaction system.
Read MorePosted by Elaine Sanchez Wilson | May 2, 2017 | Cancer, Molecular Diagnostics |
Color’s 30-gene test for hereditary cancer and Cynvenio’s next-generation sequencing breast cancer test are now offered as a unified solution for assessing breast cancer risk with cost-effective patient monitoring.
Read MorePosted by Elaine Sanchez Wilson | Apr 27, 2017 | Sexually Transmitted Diseases |
SMRT sequencing enables the detection of genomic variants for a wide range of clinical applications.
Read More